Breast Imaging Market Size, Competitive Landscape and Market Forecast - 2029

SKU: DMMI878 | Last Updated On: Jun 25 2022 | Available Formats

> Global Breast Imaging Market Expected to reach a high CAGR of 8.8% By 2029: DataM Intelligence

Global Breast Imaging Market By Technology (Ionizing (Full-Field Digital Mammography, Analog Mammography, Positron Emission Mammography, Electric Impedance Tomography, Cone-Beam Computed Tomography, PositronEmissionTomography&Computed Tomography, 3D Breast Tomosynthesis, MBI/BSGI), Non-Ionizing (MRI, Thermography, Ultrasound, Optical Imaging, Automated Whole-Breast Ultrasound)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Market Overview

The Global "Breast Imaging Market" is expected to grow at a high CAGR of 8.8% during the forecasting period (2022-2029).

  • Breast imaging is used to obtain high-resolution visualization of breast tissues and associated diseases. Breast cancer is the leading cause of breast disease that requires immediate screening, which in turn is expected to boost the growth of the breast imaging market.

  • Breast cancer can occur both in men and women, though it is majorly reported in females. The most common breast imaging tests used to determine breast cancer and related disease are ultrasound, mammography, nuclear imaging MRI, and thermography.

  • Furthermore, mammography is the most preferred imaging technique for breast cancer diagnosis for women of age 40 and above.

Market Dynamics

  • The growing incidences of breast cancer primarily drive the global market for the global breast imaging market. For instance, according to the American Institute Of Cancer Research (AICR), breast cancer is the most commonly occurring cancer in women and the second most common cancer overall.

  • There were over 2 million new cases in 2018. Other factors propelling the breast imaging market are the increasing public-private investments, funds, and grants, owing to it to increasing awareness on early detection of breast cancer and the aging population. Opportunities in emerging economies offer high growth potential as well as technological advancements in the field.

  • However, the high cost of breast imaging systems, unfavorable reimbursement scenarios, side-effects of radiation exposure may hinder the market growth of breast imaging.

Market Size and Analysis

  • By technology, the breast imaging market is segmented into ionizing breast imaging, non-ionizing breast imaging. The non-ionizing breast imaging segment is expected to show the highest CAGR during the forecast period.

  • It can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as high sensitivity to minor breast lesions in dense breast tissues, greater generation of anatomical details for diagnosis, and fewer false positives.

  • Non-ionized is sub-segmented into MRI, thermography, ultrasound, optical imaging, and automated whole-breast ultrasound.

  • The ultrasound segment accounted for the largest share of the non-ionizing breast imaging technologies share. It can be attributed to the lower risk of radiation exposure and the advantages offered by breast ultrasound such as the ability to detect lesions and their nature in dense breast tissues, and the capability to differentiate a cyst from a solid mass.

  • Ionizing is sub-segmented into analog mammography, positron emission mammography, full-field digital mammography, cone-beam computed tomography, electric impedance tomography, positron emission tomography & computed tomography, 3D breast tomosynthesis, and MBI/BSGI.

  • The mammography segment is the largest share of the ionizing breast imaging technologies market owing to technological advancements in this segment and increasing awareness.

Geographical Share

  • North America dominates the global breast imaging market, owing to it being a crucial contributor to the market as it is a technologically advanced and developed region. It has a broad base of the patient population and the presence of significant medical companies.

  • Moreover, the extensive research activities are undertaken by a majority of prominent players in the area, and the early adoption of advanced medical technologies helps the regional market. Other factors are the high spending of GDP in healthcare, especially in the US and Canada, and increasing initiatives by the government.

  • Europe is expected to show significant growth in the breast imaging market, owing to the increasing prevalence of breast cancer among women in this region. According to the United Nations Children’s Fund (UNICEF), annually in England, approximately 41,000 new cases of women are diagnosed.

  • The Asia Pacific is expected to witness significant growth owing to the increasing awareness among individuals in the region.

  • The region’s large population base also contributes to the high growth market. According to the International Association of Cancer Registries, breast cancer cases reported in Asia accounts for 39% of all breast cancers diagnosed worldwide.

Competitive Trends

  • Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New and innovative product launches are another strategy adopted by the leading players to improve their market presence.

  • March 2018, Royal Philips, a global leader in health technology, and Hologic, an innovative women’s health company, announced a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics, and services for screening, diagnosis, and treatment of women across the world.

  • The collaboration combines Hologic’s innovative mammography technologies and Philips’ leading portfolio of MRI, CT, X-ray, and ultrasound systems, advanced informatics, and a broad range of services.

  • March 2018, Hologic, received PMA approval from FDA for its innovations on the Clarity HD high-resolution 3D imaging and intelligent 2D imaging technology and are available on the 3Dimensions breast tomosynthesis system.

  • In 2017, CMR Naviscan Corporation acquired some assets of Gamma Medica Molecular Breast Imaging Technology, aiming to expand its Breast PET Imaging Solutions.

  • In 2017, Canon, Inc. established the Yokohama Development Center in Tsurumi Ward, Yokohama, aiming to expand its operations and pioneer new business opportunities.

  • In April 2016, Fujifilm India Pvt Ltd collaborated with NM Medical, for the installation of Fujifilm’s 50 Micron 3D Mammography machine-a highly advanced breast cancer diagnostic machine used to detect breast cancer among women at an early stage.

Trending Topics

Breast Cancer Diagnostics Market

Breast Implant Market

Vascular Imaging Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!